Evidence map›Paper›PMID 38560161›Full record

ArticleHeliyon2024

COVID-19 surveillance report for Sudan, 2020 to 2021.

Ahmad Izzoddeen, Sabir Abosror, Mustafa Magbol, Alaa Khalil, Mazza Abasher, Omer Albadri, Hafsa Abualgasim Osman, Esmail Esmail Mohamed, Abdalla Abdalla Mohamed, Suleiman Gamal Elgurashi and 6 more

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Herbal Self-medication Practice for Coronavirus Disease 2019 in Sudan: A Public Survey, 2021.Current therapeutic research, clinical and experimental · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ahmad IzzoddeenFETP, FMoH, Sudan.
Sabir AbosrorFETP, FMoH, Sudan.
Mustafa MagbolAlzaiem Alazhari University, Faculty of Medicine, Khartoum, Sudan.
Alaa KhalilFETP, FMoH, Sudan.
Mazza AbasherHEEC, FMoH, Sudan.
Omer AlbadriHEEC, FMoH, Sudan.
Hafsa Abualgasim OsmanHEEC, FMoH, Sudan.
Esmail Esmail MohamedHEEC, FMoH, Sudan.
Abdalla Abdalla MohamedHEEC, FMoH, Sudan.
Suleiman Gamal ElgurashiHEEC, FMoH, Sudan.
Muntasir M OsmanHEEC, FMoH, Sudan.
Tehani AminHEEC, FMoH, Sudan.
Elfadil MohamedHEEC, FMoH, Sudan.
Babiker MagboulWHO, Sudan.
Abdalla SiedahmedPublic Health Centre, Sudan.
Elfatih M MalikUniversity of Khartoum, Faculty of Medicine, Khartoum, Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Following the World Health Organization declaration, COVID-19 was first appearance in Sudan was in March 2020. Cases were reported to the Sudan Federal Ministry of Heath through the surveillance system from different sources. This study used surveillance data from 2020 to 2021 to describe the epidemiologic patterns of COVID-19 occurrence in Sudan and provide insight for better preparedness and response. Methods: Through a retrospective descriptive study, COVID19 cases records obtained from the national surveillance line-list in Surveillance and Information Directorate in Federal Ministry of Health. The analysis of data was done with SPSS version 21. Descriptive analysis done by frequencies and percentages, and further analysis through performing multivariate logistic regression. Results: Out of 48,545 suspected cases tested for COVID-19 using RT-PCR, 27,453 (56.5%) tested positive with case fatality ratio of 6.5%. Higher death rate among elderly (78% > 60-year-old) and males (70.1%). From the reported cases, 53.8% showed no symptoms, while the common symptoms among symptomatic patients were; fever (26.4%), cough (19.1%), shortness of breath (16.8%) with small proportion (4.5%) reported loss of smell and taste. Specific states, Khartoum, Gezira and Red Sea showed highest prevalence. The disease peaked four times during 2020-2021, with a proposed alert threshold of 200-250 cases per week acting as an explosion point nationwide. Conclusions: The high case fatality rate in the country requires further analysis, as well as the high proportion of asymptomatic infection. This will be ensured by improving the quality and completeness of surveillance data. A proposed threshold of 200-250 cases per week should be an alert to augment the measures of controlling the pandemic over the country, including providing enough supplies to decrease mortality.

Indexed as

COVID-19Epidemic thresholdOutbreak patternsSudanSurveillance

Identifiers

PMID38560161
PMCPMC10981027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.